Rivaroxaban 20mgTablet
Cardiac & Anti-Coagulant

Rivaroxaban 20mg

Rivaroxaban

Direct oral factor Xa inhibitor (DOAC) that provides predictable anticoagulation without routine INR monitoring, approved for stroke prevention in non-valvular atrial fibrillation, treatment and secondary prevention of DVT/PE, and VTE prophylaxis after major orthopaedic surgery. Manufactured by Cipla and Natco as a cost-effective generic alternative to Xarelto, exported for cardiology and thrombosis management programs in emerging healthcare markets.

Strengths

10mg / 15mg / 20mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Rivaroxaban 10mg / 15mg / 20mg
Dosage Form
Tablet
Available Strengths
10mg / 15mg / 20mg
Packing
10 tablets/strip
Route of Administration
Oral; 15mg and 20mg with food; 10mg with or without food
Dosage
AF: 20mg once daily with evening meal; DVT/PE: 15mg BID for 21 days, then 20mg OD; VTE prophylaxis: 10mg OD
Indications
Stroke prevention in non-valvular AF, treatment and prevention of DVT and PE, VTE prophylaxis after hip/knee surgery
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, protected from moisture
Shelf Life
36 months
Side Effects
Bleeding, anemia, dizziness, headache, bruising, nausea, elevated transaminases
Precautions
No reliable reversal agent (andexanet alfa limited); monitor renal function; avoid with strong dual CYP3A4/P-gp inhibitors; spinal/epidural hematoma risk; do not crush tablets

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Metoprolol Succinate 50mgTablet

Metoprolol Succinate 50mg

Metoprolol Succinate

Cardioselective beta-1 adrenoceptor blocker in extended-release formulation that reduces heart rate, blood pressure, and myocardial oxygen demand with once-daily dosing for hypertension, stable angina, and heart failure with reduced ejection fraction. Manufactured to USP standards by Sun Pharma and Cipla and exported globally as a key cardiovascular agent in hypertension, post-MI, and heart failure management protocols.

25mg / 50mg / 100mg
Losartan 50mgTablet

Losartan 50mg

Losartan Potassium

Selective AT1 angiotensin II receptor blocker (ARB) that reduces blood pressure, protects renal function in diabetic nephropathy, and decreases cardiovascular events in hypertensive patients with left ventricular hypertrophy, with a tolerability advantage over ACE inhibitors due to the absence of bradykinin-mediated cough. Manufactured by Cipla and Sun Pharma and exported globally as a widely-used first-line antihypertensive and renoprotective agent.

25mg / 50mg / 100mg
Ramipril 5mgTablet

Ramipril 5mg

Ramipril

Long-acting ACE inhibitor with demonstrated cardiovascular risk reduction benefits across hypertension, post-MI left ventricular dysfunction, chronic heart failure, and diabetic nephropathy, supported by landmark HOPE and REIN trial data. Available in four strengths from Sanofi and Cipla for stepwise titration, exported globally as a cornerstone RAAS agent in both primary and secondary cardiovascular prevention protocols.

1.25mg / 2.5mg / 5mg / 10mg

Need bulk pricing for Rivaroxaban 20mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote